Lyrica (Pregabalin) is a drug that is approved for the treatment of neuropathic pain as well as partial seizures in adults. In some countries (outside the United States) it has also been successfully used for the treatment of anxiety disorders. Lyrica is often preferred over opioid medications in the treatment of chronic pain as well …
Geodon (Ziprasidone) is an atypical antipsychotic that was approved by the FDA in 2001 for the treatment of schizophrenia. It has since been approved to manage both manic and mixed states of bipolar disorder. In some cases, the drug is used as an antidepressant augmentation strategy for the treatment of refractory depression, as well as …
Risperdal (Risperidone) is an atypical antipsychotic medication that has been approved since 1994 for the treatment of schizophrenia, bipolar disorder, as well as certain cases of autism. It functions as an antagonist of the neurotransmitter dopamine. By acting as an antagonist, it reduces overall dopamine activity in the brain and helps eliminate many of the …
Latuda (Lurasidone) is a relatively new atypical antipsychotic that was approved in 2013 for the treatment of schizophrenia and depressive episodes in Type 1 Bipolar disorder. Many have made the argument that since this is a “newer” antipsychotic, it’s likely to be “better” than the crop of older medications on the market. While no single …
Zyprexa (Olanzapine) is an atypical antipsychotic medication that is approved by the FDA for the treatment of schizophrenia and bipolar disorder. In relatively rare cases, it is used as an augmentation strategy for the treatment of depression. The drug is manufactured by the company Eli Lilly, and has generated billions of dollars in revenue. Despite …
Abilify (Aripiprazole) is an atypical antipsychotic drug that is commonly used to treat severe psychiatric conditions like schizophrenia and bipolar disorder. In recent years, it has been heavily marketed as an antidepressant augmentation strategy. Despite the fact that this has been one of the most profitable medications of recent years, some research has suggested that …
Wellbutrin (Bupropion) is considered an atypical antidepressant and smoking cessation aid that was first approved for medical use in 1989. It functions different than most antidepressants in that it inhibits the reuptake of stimulatory neurotransmitters norepinephrine and (to a lesser degree) dopamine. Its action as an NDRI drug generally results in increased energy, focus, and …